Literature DB >> 11694812

Serum levels of vascular endothelial growth factor and cavity formation in active pulmonary tuberculosis.

Y Abe1, M Nakamura, Y Oshika, H Hatanaka, T Tokunaga, Y Ohkubo, T Hashizume, K Suzuki, T Fujino.   

Abstract

BACKGROUND: In active pulmonary tuberculosis, certain cytokines have been postulated to be related to cavity formation, although the detailed mechanism of cavity formation is not yet known.
OBJECTIVE: We examined the relationship between cavity formation in pulmonary tuberculosis and vascular endothelial growth factor (VEGF), which functions as an angiogenesis factor.
METHODS: Forty-eight patients with active pulmonary tuberculosis were divided into two groups according to cavity formation as evaluated by chest high-resolution computed tomography. We evaluated serum VEGF levels by enzyme immunoassay.
RESULTS: Group A (with cavities) was comprised of 22 patients and group B (without cavities) was comprised of 26 patients. The serum levels of VEGF were significantly higher in group B (58.733 +/- 21.612 pg/ml) than those in normal individuals (8.739 +/- 3.656 pg/ml) and in group A (13.053 +/- 8.670 pg/ml) (Mann-Whitney U test, p = 0.0149 and p = 0.0481, respectively). Serum levels of interleukin-8 and tumor necrosis factor-alpha were not significantly different between the two groups.
CONCLUSION: These findings suggested that increased serum VEGF levels subdue cavity formation in active pulmonary tuberculosis. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11694812     DOI: 10.1159/000050557

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  14 in total

1.  Angiopoietins as biomarkers of disease severity and bacterial burden in pulmonary tuberculosis.

Authors:  N P Kumar; B Velayutham; D Nair; S Babu
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

2.  Angiogenic activity of sera from pulmonary tuberculosis patients in relation to IL-12p40 and TNFα serum levels.

Authors:  Tadeusz M Zielonka; Urszula Demkow; Dorota Michalowska-Mitczuk; Malgorzata Filewska; Beata Bialas; Katarzyna Zycinska; Michael H Obrowski; Jan Kus; Ewa Skopinska-Rozewska
Journal:  Lung       Date:  2011-05-21       Impact factor: 2.584

3.  Tuberculosis-diabetes co-morbidity is characterized by heightened systemic levels of circulating angiogenic factors.

Authors:  Nathella Pavan Kumar; Kadar Moideen; Shanmugam Sivakumar; Pradeep A Menon; Vijay Viswanathan; Hardy Kornfeld; Subash Babu
Journal:  J Infect       Date:  2016-10-04       Impact factor: 6.072

4.  Vascular endothelial growth factor levels in tuberculosis: A systematic review and meta-analysis.

Authors:  Amene Saghazadeh; Nima Rezaei
Journal:  PLoS One       Date:  2022-05-25       Impact factor: 3.752

5.  Effect of standard tuberculosis treatment on plasma cytokine levels in patients with active pulmonary tuberculosis.

Authors:  Catherine Riou; Blas Perez Peixoto; Lindi Roberts; Katharina Ronacher; Gerhard Walzl; Claudia Manca; Roxana Rustomjee; Thuli Mthiyane; Dorothy Fallows; Clive M Gray; Gilla Kaplan
Journal:  PLoS One       Date:  2012-05-14       Impact factor: 3.240

Review 6.  Clinical implications for vascular endothelial growth factor in the lung: friend or foe?

Authors:  Andriana I Papaioannou; Konstantinos Kostikas; Panagoula Kollia; Konstantinos I Gourgoulianis
Journal:  Respir Res       Date:  2006-10-17

7.  Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.

Authors:  Nathella Pavan Kumar; Vaithilingam V Banurekha; Dina Nair; Subash Babu
Journal:  PLoS One       Date:  2016-01-04       Impact factor: 3.240

8.  Network Analysis of Human Genes Influencing Susceptibility to Mycobacterial Infections.

Authors:  Ettie M Lipner; Benjamin J Garcia; Michael Strong
Journal:  PLoS One       Date:  2016-01-11       Impact factor: 3.240

9.  Immune responses in the lungs of patients with tuberculous pleural effusion without pulmonary tuberculosis.

Authors:  Diana Qama; Won-Il Choi; Kun Young Kwon
Journal:  BMC Immunol       Date:  2012-08-13       Impact factor: 3.615

10.  Correlation of serum tumor necrosis factor-alpha, interleukin-4 and soluble interleukin-2 receptor levels with radiologic and clinical manifestations in active pulmonary tuberculosis.

Authors:  Levent Kart; Hakan Buyukoglan; Ishak O Tekin; Remzi Altin; Zuhal Senturk; Inci Gulmez; Ramazan Demir; Mustafa Ozesmi
Journal:  Mediators Inflamm       Date:  2003-02       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.